BMS embraces AI drug discovery with $1.2bn Exscientia alliance

Retrieved on: 2021-05-20 08:37:30

Tags for this article:

Click the tags to see associated articles and topics

BMS embraces AI drug discovery with $1.2bn Exscientia alliance. View article details on hiswai:

Excerpt

Along with Exscientia, other players in the category include BenevolentAI, Atomwise, Recursion Pharma, and Insilico Medicine. For BMS, the ...

Article found on: pharmaphorum.com